We are live on
!
Find out more
Puma Biotechnology
PBYI
PBYI
174 hedge funds and large institutions have $2.13B invested in Puma Biotechnology in 2018 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 70 increasing their positions, 55 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
27% more repeat investments, than reductions
Existing positions increased: 70 | Existing positions reduced: 55
0.97% more ownership
Funds ownership: 94.33% → 95.31% (+0.97%)
0% more call options, than puts
Call options by funds: $82.1M | Put options by funds: $82M
7% less first-time investments, than exits
New positions opened: 25 | Existing positions closed: 27
2% less funds holding
Funds holding: 178 → 174 (-4)
12% less capital invested
Capital invested by funds: $2.42B → $2.13B (-$295M)
75% less funds holding in top 10
Funds holding in top 10: 4 → 1 (-3)
Holders
174
Holders Change
-4
Holders Change %
-2.25%
% of All Funds
3.98%
Holding in Top 10
1
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-75%
% of All Funds
0.02%
New
25
Increased
70
Reduced
55
Closed
27
Calls
$82.1M
Puts
$82M
Net Calls
+$187K
Net Calls Change
+$8.69M
Top Buyers
| 1 |
CCM
Consonance Capital Management
New York
|
+$121M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$46M |
| 3 |
State Street
Boston,
Massachusetts
|
+$27.9M |
| 4 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$27.4M |
| 5 |
Jennison Associates
New York
|
+$27M |
Top Sellers
| 1 |
RG
Redmile Group
San Francisco,
California
|
-$74.6M |
| 2 |
Janus Henderson Group
London,
United Kingdom
|
-$68.4M |
| 3 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$34M |
| 4 |
D.E. Shaw & Co
New York
|
-$33.8M |
| 5 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$25.3M |
